Manufacture of pharmaceutical preparations
CURIDA AS
Revenue 2024
NOK 279.8m
Operating profit
NOK 3.1m
Equity
NOK 26.1m
Incorporated
2015
Employees
133
Share capital
NOK 15.0m
Key figures · 2024
Current ratio
0.72
Equity ratio
12.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 1.1% | |
| Net margin (%%) | -4.8% | |
| Return on assets (%%) | 1.4% | |
| Likviditet | ||
| Current ratio | 0.72 | |
| Working capital | −53.1m | |
| Soliditet | ||
| Equity ratio (%%) | 12.0% | |
| Debt-to-equity ratio | 7.33 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.